Table 2.
Multivariate analysis of the risk factors for poor prognosis (non-ER).
| β | SE | Wald | P-value | OR | 95% CI | |
|---|---|---|---|---|---|---|
| Male | 0.603 | 0.21 | 8.212 | 0.004 | 1.827 | 1.21–2.76 |
| Age (>55 years) | −0.106 | 0.295 | 0.13 | 0.718 | 0.899 | 0.504–1.603 |
| Size (>1 cm) | −0.289 | 0.207 | 1.955 | 0.162 | 0.749 | 0.499–1.123 |
| Solid components | 0.15 | 0.533 | 0.079 | 0.779 | 1.161 | 0.409–3.298 |
| Halo | −1.002 | 0.51 | 3.851 | 0.050 | 0.367 | 0.135–0.999 |
| Later relative arrival time of microbubble | 0.074 | 0.246 | 0.09 | 0.764 | 1.077 | 0.665–1.744 |
| Blood-rich enhancement | 0.524 | 0.249 | 4.423 | 0.035 | 1.688 | 1.036–2.75 |
| Heterogeneous enhancement pattern | 0.101 | 0.303 | 0.111 | 0.739 | 1.106 | 0.611–2.002 |
| Margin | 0.054 | 0.321 | 0.028 | 0.867 | 1.055 | 0.562–1.981 |
Number reported in bold are statistically significant.
OR, odds ratio; CI, confidence interval.